HopeStage
Back to all studies
CompletedNCT00283595

Growth hormone and bone health in women with anorexia

About this title

Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa

Read the official source — NCT00283595
Medication studyAges 14–45United StatesEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 14 years to 45 years.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2006
Recruitment status
Completed
Enrollment listed in the registry
21
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 14 Years to 45 Years
Official registry ID
NCT00283595
Official title
Show the full official title

Effect of Supraphysiological rhGH on Bone Metabolism in Patients With Anorexia Nervosa

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Recombinant Human Growth Hormone and Placebo for Recombinant Human Growth Hormone.

Who was this study for?

Listed age limits: 14 years to 45 years.

Want to explore more studies?

Explore studies